Day: June 21, 2021

County Bancorp Announces Improvement in Credit Quality

Written by Customer Service on June 21, 2021. Posted in Public Companies.

Improved milk prices and risk management strategies strengthened the Company’s credit portfolio, resulting in a meaningful reduction in allowances for loan and lease losses MANITOWOC, Wisc., June 21, 2021 (GLOBE NEWSWIRE) — County Bancorp, Inc. (Nasdaq: ICBK; the “Company”), the parent company for Investors Community Bank, announced today that as of May 31, 2021, the Company’s non-performing assets decreased $13.3 million or 29.7% compared to March 31, 2021. In addition, the Company’s adverse classified assets (a non-GAAP measure; see below for a reconciliation to GAAP metrics) as of May 31, 2021, decreased $29.8 million or 34.9% compared to March 31, 2021. “A sustained recovery in the dairy market is benefiting our clients’ cash flows, and in turn, reducing the credit risk in our loan portfolio,” said Tim Schneider,...

Diamondback Energy, Inc. Fully Redeemed $191 Million of 4.625% Senior Notes Due 2021

Written by Customer Service on June 21, 2021. Posted in Public Companies.

MIDLAND, Texas, June 21, 2021 (GLOBE NEWSWIRE) — Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback” or the “Company”) announced today that the Company fully redeemed the $191 million aggregate principal amount of outstanding legacy 4.625% Senior Notes Due 2021 of Energen Corporation, a subsidiary of the Company. The repayment of these notes will reduce cash interest expense by approximately $9 million annually. “By using internally generated cash flow as well as proceeds from our previously announced Permian non-core asset sales to retire this tranche of bonds, we reduced our absolute debt load, decreased our interest expense and strengthened our balance sheet,” stated Travis Stice, Chief Executive Officer of Diamondback. “We expect to use additional internally generated free cash flow as well as proceeds...

Nurix Therapeutics Announces Appointment of Stefani A. Wolff as Chief Operating Officer and Executive Vice President, Product Development

Written by Customer Service on June 21, 2021. Posted in Public Companies.

SAN FRANCISCO, June 21, 2021 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a biopharmaceutical company developing targeted protein modulation drugs, today announced that Stefani A. Wolff has joined the company as chief operating officer and executive vice president of product development. Ms. Wolff brings to Nurix over 30 years of leadership experience in oncology and immunology most recently from Principia Biopharma Inc., where she served as chief development officer and formerly senior vice president of strategy and operations overseeing Principia’s portfolio including BTK targeted agents. During her tenure at Principia, she successfully guided drug pipeline strategy and led many functions over time, including the company’s manufacturing and technical operations, regulatory and quality, clinical operations, project...

Lam Research Reinforces its ESG Goals with New $1.5 Billion Sustainability-Linked Revolving Credit Facility

Written by Customer Service on June 21, 2021. Posted in Public Companies.

FREMONT, Calif., June 21, 2021 (GLOBE NEWSWIRE) — Lam Research Corp. (Nasdaq: LRCX) today announced the recent closing of an inaugural $1.5 billion sustainability-linked credit facility, demonstrating the importance of the company’s environmental, social, and governance (ESG) goals. Over the credit facility term, Lam will receive a pricing adjustment if the company is above or below performance targets around annual energy savings and maintaining its high standard of employee safety. “Lam strives to incorporate ESG into everything we do – from our operations and workplace practices, to how we source our materials and design our products,” said Doug Bettinger, executive vice president and chief financial officer of Lam Research. “The new sustainability-linked credit facility is part of our overall management focus on financial performance...

Grom Social Enterprises, Inc. Announces Closing of $10.0 Million Public Offering

Written by Customer Service on June 21, 2021. Posted in Public Companies.

BOCA RATON, June 21, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Grom Social Enterprises, Inc. (NASDAQ: GROM) (“Grom”, the “Company”), a social media platform and original content provider for children under the age of 13, today announced the closing of its previously announced underwritten public offering of 2,409,639 units at a public offering price of $4.15 per unit for aggregate gross proceeds of approximately $10.0 million prior to deducting underwriting discounts, commissions, and other offering expenses. Each unit issued in the offering was comprised of one share of common stock and one warrant to purchase one share of common stock. Each warrant is exercisable for one share of common stock at an exercise price of $4.565 per share and will expire five years from issuance. In addition, the Company granted the underwriters...

Cassava Sciences Selects Clinical Research Organization for Phase 3 Clinical Program in Alzheimer’s Disease

Written by Customer Service on June 21, 2021. Posted in Public Companies.

Selection of Premier Research as CRO Marks Significant Milestone Toward Initiation of Phase 3 Program of Simufilam in Alzheimer’s Disease AUSTIN, Texas, June 21, 2021 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer’s disease, today announced the selection of Premier Research International as its clinical research organization (CRO) to help conduct the Phase 3 clinical program of simufilam for Alzheimer’s disease. Consistent with previous guidance, Cassava Sciences plans to initiate this Phase 3 program in the second half of 2021. “Having completed over 250 clinical studies in neuroscience, we believe Premier Research International understands how to conduct clinical studies in patients with Alzheimer’s disease,” said Remi Barbier, President & CEO of Cassava Sciences....

NextCure and Collaborators Publish Preclinical Data on Novel Immunomedicine NC410

Written by Customer Service on June 21, 2021. Posted in Public Companies.

BELTSVILLE, Md., June 21, 2021 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced the publication of preclinical data in the online journal eLife establishing NC410 as a novel immunomedicine targeting immune-excluded regions of collagen-rich tumors and enabling normalization of the tumor immune microenvironment. NC410, currently being evaluated in a Phase 1/2 clinical trial in patients with advanced or metastatic solid tumors, is a first-in-class immunomedicine designed to block immune suppression mediated by LAIR-1, an immunomodulatory receptor expressed on T cells and myeloid cells, including dendritic cells. “The blockade of LAIR-1 binding to collagen in...

Kymera Therapeutics Appoints Elaine Caughey, MBA, as Chief Business Officer

Written by Customer Service on June 21, 2021. Posted in Public Companies.

WATERTOWN, Mass., June 21, 2021 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, today announced the appointment of Elaine Caughey, MBA, as Chief Business Officer. Ms. Caughey joins Kymera with over 20 years of experience in the biotechnology industry, including leadership roles in corporate development, business and commercial operations, new product strategy, and investing. “Elaine brings a broad set of capabilities that will be invaluable in helping Kymera continue to grow our pipeline and scale our organization into a fully integrated degrader medicines company,” said Nello Mainolfi, PhD, Co-Founder, President and CEO, Kymera Therapeutics. “We are excited to have Elaine join...

EssilorLuxottica : EssilorLuxottica welcomes favorable outcome of the arbitration confirming material breaches by GrandVision

Written by Customer Service on June 21, 2021. Posted in Mergers And Acquisitions.

EssilorLuxottica welcomes favorable outcome of the arbitration confirming material breaches by GrandVision Charenton-le-Pont, France (June 21, 2021 – 10.00 p.m.) – EssilorLuxottica welcomes the favorable award issued today by the arbitral tribunal in the proceedings initiated by HAL and GrandVision. The arbitral tribunal ruled that EssilorLuxottica has the option to terminate the acquisition of GrandVision due to GrandVision’s material breaches of its obligations to EssilorLuxottica. EssilorLuxottica is reviewing its options in relation to the transaction and in due course will communicate its determination on the way forward. “Although we regret that GrandVision’s misconduct has led to this current situation, we are pleased that the tribunal accepted our position on the parties’ commitments and the importance of honoring those commitments.”...

CAVU Resources, Inc. announces name change, engages investment bank, enters into agreement to acquire several companies, and schedules shareholder call

Written by Customer Service on June 21, 2021. Posted in Public Companies.

CHARLOTTE, N.C., June 21, 2021 (GLOBE NEWSWIRE) — CAVU Resources, Inc. (OTC: CAVR) follows through on its intention to change its name from CAVU Resources, Inc. to LiveToBeHappy, Inc. The Board of Directors voted to adopt the new name at its quarterly meeting on June 17th and the company is announcing it will make these changes effective immediately upon filing the appropriate documents with the State of Nevada. “People had to adapt because of living through a Pandemic – they had to adapt to living, working, educating, and entertaining themselves within the confines of their residence. An individual’s residence is now more important than ever – especially in their pursuit of happiness. Each of our communities and residences are designed with this in mind – so changing our name to Live to be Happy makes sense – it reminds all of...

M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30

Day: June 21, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals